{"SPADE_UN_20592": {"Sequence Information": {"Peptide Name": "pEM-2 [W5K,K8W9L10Del]", "Sequence": "KKWRKWLAKK", "Sequence Length": 10, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P24605", "uniprotUrl": "http://www.uniprot.org/uniprot/P24605", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Novel antimicrobial peptides with high anticancer activity and selectivity.", "Pubmed ID": "25970292", "Reference": "PLoS One. 2015;10:e0126390", "Author": "Chu HL, Yip BS, Chen KH, Yu HY, Chih YH, Cheng HT, Chou YT, Cheng JW", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25970292"}, {"Title": "Boosting salt resistance of short antimicrobial peptides.", "Pubmed ID": "23716061", "Reference": "Antimicrob Agents Chemother. 2013;57:4050-4052", "Author": "Chu HL, Yu HY, Yip BS, Chih YH, Liang CW, Cheng HT, Cheng JW", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/23716061"}, {"Title": "Boosting Synergistic Effects of Short Antimicrobial Peptides With Conventional Antibiotics Against Resistant Bacteria.", "Pubmed ID": "34733262", "Reference": "Front Microbiol. 2021;12:747760", "Author": "Wu CL, Peng KL, Yip BS, Chih YH, Cheng JW", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/34733262"}], "Mass": 1371.72, "PI": 11.39, "Net Charge": 6, "Hydrophobicity": -2.02, "Frequent Amino Acids": "KWA", "Absent Amino Acids": "CDEFGHIMNOPQSTUVY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 8, "Positive Residues": 6, "Negative Residues": 0, "SPADE ID": "SPADE_UN_20592", "Similar Sequences": [{"SPADE_ID": "SPADE_N_02322", "Similarity": 1.0, "Sequence": "FISNDECPSEYYYHCRLKCNADEHAIRYCADFSICCKLKIIEIHGQKKW"}, {"SPADE_ID": "SPADE_N_03174", "Similarity": 1.0, "Sequence": "FISNDECPSEYYHCRLKCNADEHAIRYCADFSICCKLKIIEIDGQKKW"}, {"SPADE_ID": "SPADE_N_06612", "Similarity": 1.0, "Sequence": "KKKKKKKKWRKWLAKK"}], "Hemolytic Activity": "Human diploid fibroblasts HFW:50% Cell death=>100 µM,Human erythrocytes:-=NA", "Target Organism": "Escherichia coli ATCC 25922(MIC=6.25µg/ml),Staphylococcus aureus ATCC 25923(MIC=1.6µg/ml),Staphylococcus aureus ATCC 25923(MIC=25µg/ml),Staphylococcus aureus ATCC 25923(MIC=50µg/ml),Staphylococcus aureus ATCC 25923(MIC=>50µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=1.6µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=25µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=>50µg/ml),Escherichia coli ATCC 25922(MIC=>50µg/ml),Human lung carcinoma A549(IC50=>50µM),Human squamous oral carcinoma OECM-1(IC50=>50µM),Human Lung adenocarcinoma PC-9(IC50=>50µM),Human tongue carcinoma SAS(IC50=>50µM),Human oral cancer C9(IC50=>50µM),Escherichia coli ATCC 25922(MIC=>50µg/ml),Staphylococcus aureus ATCC 25923(MIC=>50µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=>50µg/ml),Enterococcus faecium BCRC 15B0132(MIC=>64µg/ml),Acinetobacter baumannii BCRC 14B0091(MIC=>64µg/ml),Acinetobacter baumannii BCRC 14B0097(MIC=>64µg/ml),Acinetobacter baumannii BCRC 14B0100(MIC=>64µg/ml),Escherichia coli BCRC 13B0198(MIC=64µg/ml),Escherichia coli BCRC 13B0207(MIC=>64µg/ml)"}}}